Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Andrew DeGasperi

BNP Paribas · covers Technology, Healthcare

Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q3 (8 quarters).

Questions
23on tracked calls
Challenge rate
9%2 of 23 questions
Companies
7questioned at least once
Reporting periods
8with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 23 of 23 questions from 7 companies

VEEVVeeva Systems Inc.8 questions · 8 reporting periods · 0 of 8 challenging
VEEV company page →

Calendar 2026 Q3

I just wanted to understand how is that going.

Competitive DynamicsM&ATranscript · FY2027 Q2 →
Show response

Peter said both Veeva and IQVIA are very happy with the partnership, customers appreciate the reduced hassle, and he feels far better about the relationship than two years ago.

Calendar 2026 Q2

Do you think it could potentially cannibalize some of the revenue that you get from those customers?

Revenue GrowthCompetitive DynamicsCloud & AITranscript · FY2027 Q1 →
Show response

Peter said Falcon is fully accretive as it addresses a labor market Veeva does not serve today and still requires a system of record.

Calendar 2026 Q1

how firm are those commitments

Competitive DynamicsRevenue GrowthTranscript · FY2026 Q4 →
Show response

Paul said commitments are firm based on 140 live customers and 2 top 20 live in major markets. Greater risk is Salesforce custom builds failing and coming back to Veeva. Peter added all 10 Veeva projects are started and going to a stable product. Brian confirmed services guidance accounts for top 20 projects at various phases.

Calendar 2025 Q4

I was just wondering why is that the case

Revenue GrowthCompetitive DynamicsTranscript · FY2026 Q3 →
Show response

Brian cited overall CRM health beyond top 20, win-back potential, and business diversity with 80% of revenue outside CRM growing well. Always multiple paths to 2030. Peter added Crossix could be as large as CRM suite by 2030.

Calendar 2025 Q3

can you comment at any potential verbal commitments on EDC

DemandCapex InvestmentTranscript · FY2026 Q2 →
Show response

Peter said they do not disclose EDC verbal commitments; CRM verbal updates are shared due to the competitive dynamic during the Salesforce transition. Brian said Generation Veeva hiring was larger class in Q2 but in line with expectations.

Calendar 2025 Q2

have those investments been made in terms of people and headcount? Is that already in place

Product LaunchCapex InvestmentTranscript · FY2026 Q1 →
Show response

Peter said the core team is in place and will grow incrementally over two to four years. On M&A, keeping a wide aperture for synergistic acquisitions, most likely in horizontal applications. Very disciplined approach.

Calendar 2025 Q1

is that part of what's giving you confidence in terms of the R&D growth for the year

DemandRevenue GrowthTranscript · FY2025 Q4 →
Show response

Paul said clinical trial starts don't drive R&D confidence since most contracts are enterprise license agreements unaffected by trial volume fluctuations.

Calendar 2024 Q4

do we start seeing an impact to gross margin? In other words, that royalty that you paid for Salesforce for Veeva CRM

MarginProduct LaunchTranscript · FY2025 Q3 →
Show response

Brian noted secular margin improvement from platform shift but said it will take time and be spread between now and 2030 as migrations are long-range.

CDNSCadence Design Systems3 questions · 2 reporting periods · 0 of 3 challenging
CDNS company page →

Calendar 2026 Q1

marquee AI infrastructure company expanded the use of signoff solutions. I just want to clarify

Competitive DynamicsDemandTranscript · FY2026 Q1 →
Show response

Devgan confirmed the customer is an AI infrastructure/ASIC company without naming them specifically. Noted Innovus and signoff solutions gaining share at TSMC and other foundries.

does this mean that, that physical AI time line has been brought forward?

Show response

Devgan said labor productivity TAM expansion from agentic AI plus add-on capabilities could accelerate monetization beyond original 2 contract cycle estimate.

Calendar 2025 Q4

You mentioned several times in the prepared remarks about taking share across the board. And I was just curious, is this kind of a change relative to previous quarters?

Competitive DynamicsRevenue GrowthTranscript · FY2025 Q4 →
Show response

Anirudh confirmed competitive position improved. Share gains in hardware, IP, EDA, 3D-IC. Holding strong position in analog, gaining in digital and verification. R&D investments paying off with broader flow adoption.

DDOGDatadog3 questions · 2 reporting periods · 0 of 3 challenging
DDOG company page →

Calendar 2026 Q2

I was wondering, did you see rising demand for the AI monitoring tool, particularly with open source tools being deployed across enterprises?

Show response

Olivier said AI/LLM monitoring volume has rapidly accelerated over the past couple of quarters from a very small base a year ago, spanning both traditional companies and newer AI natives, while noting the category is still very early and likely to change.

Calendar 2025 Q2

should we expect the number of the attach rates in terms of the 3 or 4 more products per customer sort of accelerate at this level

Subscriber GrowthRevenue GrowthTranscript · FY2025 Q2 →
Show response

Obstler expected continuation of land-and-expand trends. Pomel added that balancing upsell incentives with new customer acquisition is a constant focus of territory management and sales planning.

would you say that's been broad-based in terms of the productivity across both international and domestic

Capex InvestmentCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Obstler detailed higher international investment intensity in markets like Brazil, India, APJ, and Middle East, driven by bottoms-up TAM and coverage analysis, while North America still has plenty of opportunity.

IOTSamsara Inc.3 questions · 3 reporting periods · 1 of 3 challenging
IOT company page →

Calendar 2026 Q2

is there a difference in the economics that is software only versus a more traditional sale that includes hardware?

MarginProduct LaunchTranscript · FY2027 Q1 →
Show response

Dominic confirmed software-only deals are gross-margin accretive since hardware amortization is a top COGS line, and expects more software-only products.

Calendar 2025 Q3

I noticed it slowed down slightly. Just wondering, is this a function of the fact that you're landing larger customers?

ChallengingDemandRevenue GrowthTranscript · FY2026 Q2 →
Show response

Dominic reframed to ARR mix and growth, the cohort up 35% year over year, now 59% of ARR vs 57% a year ago, plus a record number of $1M+ additions.

Calendar 2025 Q1

I'm just wondering, do you have any data that would indicate that, look, you're not as exposed to any tariff blowbacks

Trade TariffsMacroeconomicTranscript · FY2025 Q4 →
Show response

Sanjit had no cross-border data on hand but said most customers run domestic operations (food & beverage, construction), implying limited direct tariff exposure.

ZSZscaler3 questions · 3 reporting periods · 1 of 3 challenging
ZS company page →

Calendar 2026 Q2

are you considering potentially doing the same maybe at the same time next year

Cost PressurePricingTranscript · FY2026 Q3 →
Show response

Kevin noted the earlier price increase had no negative impact and pricing is reviewed dynamically. Jay attributed the cost pressure to AI data center demand creating component shortages, calling it a fairly unique situation.

Calendar 2025 Q3

I think on the last earnings call, you said that we're contributing about half of the $140 million of ARR. I think now you're saying it's about $95 million

ChallengingM&ARevenue GrowthTranscript · FY2025 Q4 →
Show response

Kevin clarified prior call discussed expected ARR at close (not full-year). Recognized $83M at close, guiding $95M for FY2026 assuming low double-digit growth. Taking prudent approach given MDR providers' historically higher churn.

Calendar 2025 Q2

our checks found that Zscaler could benefit greatly from the federal business, and I know it's not a big contributor of revenue today

Regulation PolicyDemandTranscript · FY2025 Q3 →
Show response

Jay said federal in line with expectations. Cost reduction push in government works in Zscaler's favor vs legacy firewall vendors. Remo added not expecting significant Fed strength in Q4 guide. Well-positioned in 14 of 15 cabinet agencies.

SNPSSynopsys2 questions · 1 reporting period · 0 of 2 challenging
SNPS company page →

Calendar 2026 Q2

I just want to ask a question on the organic revenue for the quarter

Show response

Shelagh addressed the channel accounting mechanics but largely confirmed the analyst's 3-4% organic estimate, noting timing of upfront hardware revenue between Q3 and Q4.

you mentioned about the leading HPC provider successfully taping out the next generation of AI accelerator

Cloud & AICompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Sassine confirmed this is not the first hyperscaler tapeout and emphasized universal adoption of the full Synopsys portfolio across all COT hyperscaler programs, highlighting IP customization opportunity.

Show 1 more company
PTCPTC Inc.1 question · 1 reporting period · 0 of 1 challenging
PTC company page →

Calendar 2026 Q2

has something changed in the market that has led you to win that deal?

Competitive DynamicsDemandTranscript · FY2026 Q3 →
Show response

Barua gave a quantified answer, saying displacement value has doubled year-over-year and crediting vertical expertise and the AI road map.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
VEEV Veeva Systems Inc.80%none of 8 questions
CDNS Cadence Design Systems30%none of 3 questions
DDOG Datadog30%none of 3 questions
IOT Samsara Inc.333%1 of 3 questions
ZS Zscaler333%1 of 3 questions
SNPS Synopsys2—Rate withheld: fewer than 3 questions
PTC PTC Inc.1—Rate withheld: fewer than 3 questions
  • VEEV
    Veeva Systems Inc. · 8 questions
    0%none of 8 questions
  • CDNS
    Cadence Design Systems · 3 questions
    0%none of 3 questions
  • DDOG
    Datadog · 3 questions
    0%none of 3 questions
  • IOT
    Samsara Inc. · 3 questions
    33%1 of 3 questions
  • ZS
    Zscaler · 3 questions
    33%1 of 3 questions
  • SNPS
    Synopsys · 2 questions
    —rate withheld: under 3 questions
  • PTC
    PTC Inc. · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q410%none of 1 question1
2025 Q120%none of 2 questions2
2025 Q240%none of 4 questions3
2025 Q3367%2 of 3 questions3
2025 Q420%none of 2 questions2
2026 Q130%none of 3 questions2
2026 Q270%none of 7 questions6
2026 Q310%none of 1 question1
  1. 2024 Q41 question · challenge rate 0% (none of 1 question) · 1 company
  2. 2025 Q12 questions · challenge rate 0% (none of 2 questions) · 2 companies
  3. 2025 Q24 questions · challenge rate 0% (none of 4 questions) · 3 companies
  4. 2025 Q33 questions · challenge rate 67% (2 of 3 questions) · 3 companies
  5. 2025 Q42 questions · challenge rate 0% (none of 2 questions) · 2 companies
  6. 2026 Q13 questions · challenge rate 0% (none of 3 questions) · 2 companies
  7. 2026 Q27 questions · challenge rate 0% (none of 7 questions) · 6 companies
  8. 2026 Q31 question · challenge rate 0% (none of 1 question) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Competitive Dynamics9
  • Revenue Growth9
  • Demand8
  • Cloud & AI4
  • M&A3
  • Product Launch3
  • Capex Investment3
  • Margin2
  • Cost Pressure1
  • Pricing1
Show all 14 topics
  • Trade Tariffs1
  • Macroeconomic1
  • Regulation Policy1
  • Subscriber Growth1